Heart specific PGC-1α deletion identifies metabolome of cardiac restricted metabolic heart failure
- PMID: 29931052
- DOI: 10.1093/cvr/cvy155
Heart specific PGC-1α deletion identifies metabolome of cardiac restricted metabolic heart failure
Abstract
Aims: Heart failure (HF) is associated with drastic changes in metabolism leading to a cardiac energy deficiency well as maladaptive changes in multiple other tissues. It is still unclear which of these changes originates from cardiomyocyte metabolic remodelling or whether they are induced secondarily by systemic factors. Our aim here was to induce cardiac restricted metabolic changes mimicking those seen in HF and to characterize the associated metabolite changes in the heart, circulation, and peripheral tissues.
Methods and results: We generated a cardiac specific PGC-1α knockout mice (KO) to specifically induce metabolic dysregulation typically accompanied by HF and performed a non-targeted LC-MS metabolite profiling analysis of heart, plasma, liver, and skeletal muscle to identify metabolites associated with cardiac specific metabolic remodelling. The KO animals developed a progressive cardiomyopathy with cardiac dilatation leading to fatal HF. At 17 weeks of age, when significant remodelling had occurred but before the onset of HF, isolated PGC-1α deficient cardiomyocytes had suppressed glucose and fatty acid oxidation as well as blunted anaerobic metabolism. KO hearts displayed a distinctive metabolite profile with 92 significantly altered molecular features including metabolite changes in energy metabolism, phospholipid metabolism, amino acids, and oxidative stress signalling. Some of the metabolite changes correlated with the specific parameters of cardiac function. We did not observe any significant alterations in the metabolomes of the other measured tissues or in plasma.
Conclusions: Heart specific PGC-1α KO induces metabolic, functional, and structural abnormalities leading to dilating cardiomyopathy and HF. The metabolic changes were limited to the cardiac tissue indicating that cardiomyocyte metabolic remodelling is not sufficient to evoke the body wide metabolic alterations usually associated with HF.
Similar articles
-
Pathological Remodeling of the Myocardium in Chronic Heart Failure: Role of PGC-1α.Bull Exp Biol Med. 2018 Apr;164(6):794-797. doi: 10.1007/s10517-018-4082-1. Epub 2018 Apr 16. Bull Exp Biol Med. 2018. PMID: 29658071
-
PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.Circ Res. 2011 Sep 16;109(7):783-93. doi: 10.1161/CIRCRESAHA.111.243964. Epub 2011 Jul 28. Circ Res. 2011. PMID: 21799152 Free PMC article.
-
Metabolomic Analysis of the Skeletal Muscle of Mice Overexpressing PGC-1α.PLoS One. 2015 Jun 26;10(6):e0129084. doi: 10.1371/journal.pone.0129084. eCollection 2015. PLoS One. 2015. PMID: 26114427 Free PMC article.
-
Metabolic remodelling in human heart failure.Cardiovasc Res. 2011 May 1;90(2):251-7. doi: 10.1093/cvr/cvr052. Epub 2011 Mar 3. Cardiovasc Res. 2011. PMID: 21372005 Review.
-
An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.Int J Cardiol. 2013 Oct 9;168(4):3160-72. doi: 10.1016/j.ijcard.2013.07.150. Epub 2013 Aug 6. Int J Cardiol. 2013. PMID: 23932046 Review.
Cited by
-
Mitochondrial quality control in human health and disease.Mil Med Res. 2024 May 29;11(1):32. doi: 10.1186/s40779-024-00536-5. Mil Med Res. 2024. PMID: 38812059 Free PMC article. Review.
-
Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases.Signal Transduct Target Ther. 2024 Mar 1;9(1):50. doi: 10.1038/s41392-024-01756-w. Signal Transduct Target Ther. 2024. PMID: 38424050 Free PMC article. Review.
-
Reticulon 3 deficiency ameliorates post-myocardial infarction heart failure by alleviating mitochondrial dysfunction and inflammation.MedComm (2020). 2024 Feb 28;5(3):e503. doi: 10.1002/mco2.503. eCollection 2024 Mar. MedComm (2020). 2024. PMID: 38420163 Free PMC article.
-
Marine fungus Aspergillus c1. sp metabolite activates the HSF1/PGC-1α axis, inducing a thermogenic program for treating obesity.Front Pharmacol. 2024 Jan 25;15:1320040. doi: 10.3389/fphar.2024.1320040. eCollection 2024. Front Pharmacol. 2024. PMID: 38333010 Free PMC article.
-
SMYD1a protects the heart from ischemic injury by regulating OPA1-mediated cristae remodeling and supercomplex formation.Basic Res Cardiol. 2023 May 22;118(1):20. doi: 10.1007/s00395-023-00991-6. Basic Res Cardiol. 2023. PMID: 37212935 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous